Member Info for beinthelead

Or…

What data will they be analysing and subsequently presenting? A lolly stick under the tongue to check for spots?? Yep - no spots. Safe.

They’ve got reams of PK data containing metabolites of the drug. Even without Biopsy data they’ll have the implication it worked last November.

Data WILL contain PK/PD data. You literally cannot fake this. A ‘working’ version will stand out like a sore thumb.

Anyway, back to the lounger.

Ah, OK. Fair enough. Sensible strategy.

Re hostile takeover - no chance. AS is a shrewd guy (if not a calendar hater). He’d just release data from C1-3 if there was a sniff of a bid. They had enough data this time last year to prove the platform. They’ve sat, built and waiting.

Biopsies will make this share meet you expectations.

Prof - why do you fear the SP falling below 95p? I’d sell now if that’s the concern, before it does. Because without news, it’ll certainly make that level.

It’ll land when it lands. The rerate will not be affected by the SP at the time it happens.

SP will suffer until he mails the RNS. Simple.

Sit. Wait. Don’t fear what happens in the meantime.

Belgrano - that’s nonsense. Absolute nonsense.

Take of leave views, most just want to pass on experience that’s burnt them to deter others.

Agreed though - lots of trolls around.

No. Very clear. Q4, end of 2022. Crystal.

Agreed. Green has never looked so good.

You’re absolutely correct.

Unfortunately, this is a financial investment that makes the situation more complex. It’s very simple in reality; take advantage of it going to the wire (possible delay).

The delay doesn’t change the investment case, quite obvious for the reasons you state. But it does change the SP. Take advantage of the new Poundland facade while it’s there. Or be quiet and hold.

AS creates this tension. After all, it wouldn’t be there if we had news in October.

He did. This is AIM. It’s what they do - not bad in itself. But best to expect it and prepare for it.

Nailed it again Apre. Still think it’s Marik. Weird fella.

Right on time, TW’s supporters arrive.

Please do the opposite to whatever advice is filtered down from that charlatan.

Belgrano - we exchanged a few messages some time ago when I was invested here. It’s typically where this was going, but poor nonetheless.

Tom Winifrith followers will kick themselves now.

Think that account is Marik. Seen that oddness before.

TW/truant will be nursing their losses on SBTX. After hours placing. Tremendous disaster they’re long on.

Agreed Rip - we’re due another article.

There’s a lot of defending going on across the platforms. LTHs are here for the tech and are convinced by the impending outcome. Very simple. Delays happen, no problem with the tech.

However…

The defence is not for the tech, but the SP. Lots of concern/worry/anguish over where the SP is/could be on slippage.

So - Trial ongoing, great tech, progressing brilliantly. Avacta have been fantastic in this regard. Funding - genius. And must have ‘collateral’ (data) to substantiate.

But - The SP. It’s likely to drop to levels where most can fill their boots if he fails to deliver on a Q4 data update. As in, lower than placing. Investors rejoice! That’s where it’ll go. His comm’s and planning are dire. This isn’t a 40+ day slippage either. It’s months.

Therefore; if you’re tracking and ‘investing’ in the SP, by all means moan. Its warranted. Invested for the tech - let it play out. I believe they’re about to revolutionise oncology.

Wrong Timster. We got the Trinity Delta RNS yesterday which said we’re going higher. Keep up.

Ah… there you go.

How long you been here?

Who says it’s data from the trial??

The fact they’ve filed it is what excites people.

Toukankahmoon

Another thread I’ll report until it’s deleted.

I’ll continue to do so until Derek leaves.

Still significantly more than the $12m they paid GB for the rights.